Evaluate Efficacy and Safety Of Tolterodine Extended Release Capsule Compared With Tolterodine Immediate Release Tablet
Clinical trial NCT00139724 · COMPLETED
Trial details
- NCT number
- NCT00139724
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-05-01
- Primary completion
- 2006-10-01
- Enrollment
- 260
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.